Cypress Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CYPRESS PHARM, and what generic and branded alternatives to CYPRESS PHARM drugs are available?
CYPRESS PHARM has five approved drugs.
Drugs and US Patents for Cypress Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cypress Pharm | CARBINOXAMINE MALEATE | carbinoxamine maleate | TABLET;ORAL | 090417-001 | Aug 23, 2010 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Cypress Pharm | ELIPHOS | calcium acetate | TABLET;ORAL | 078502-001 | Nov 25, 2008 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Cypress Pharm | CARBINOXAMINE MALEATE | carbinoxamine maleate | SOLUTION;ORAL | 090418-001 | May 4, 2010 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.